Carbs last or first? study tests best pre-workout meal order for athletes
NCT ID NCT07503990
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at whether eating carbohydrates at the end of a pre-exercise meal (instead of at the start) changes how the body burns fat and carbs during exercise and affects cycling performance. Eighteen healthy, trained male athletes ate a standard meal in two different orders on separate days, then did a cycling test. Researchers measured fat burning, blood sugar, and time-trial performance to see if meal order matters.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- meal pattern (carbohydrate-last vs carbohydrate-first)
- What this could lead to
- If it works, this could help athletes optimize their pre-exercise meal for better fat burning and performance.
- What could go wrong
- This is a small, early study in healthy male athletes only, so results may not apply to others. The effect on performance may be small or absent.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
18 people
The number who actually took part.
- Started
-
Apr 2026
- Finished
-
Jun 2026
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 64 years
- Sex
-
Male participants only
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Adult (18-64 years old) * Men * Endurance-trained athletes (meeting training and performance caliber criteria ≥Tier 2; McKay et al., 2022) * Healthy (meeting the exclusion criteria for medical conditions) * Normal glucose tolerant according to the latest criteria established by the American Diabetes Association (2024): HbA1c \<5.7%, fasting plasma glucose \<5.6 mmol/L (100 mg/dL) or 2-h plasma glucose \<7.8 mmol/L (140 mg/dL) during a 75-g OGTT * Able and willing to provide informed consent and safely comply with study procedures Exclusion Criteria: * Any medical condition or behaviour deemed either to pose undue personal risk to the participant or introduce bias into the experiment (e.g. cardiovascular disease; alcohol or substance abuse; any condition affecting the glucose or lipid metabolism, reviewed on a case by case basis) * Any reported medication or supplementation that may interfere with the glucose metabolism (e.g., acarbose, insulin, metformin, semaglutide, thiazolidinediones, sulfonylureas, corticosteroids, thiazide diuretics) or lipid metabolism (e.g., statins, nicotinic acid, colestyramine anhydrous, ezetimibe, fibrates, L-carnitine). Other medication and supplementation will be reviewed on a case by case basis. * Known food allergy, intolerance or hypersensitivity to any of the test meal ingredients * Recent change in body mass (± 2 kg in the last 2 months) * Smoking
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Endurance exercise are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Cidade do Futebol
Lisbon, Oeiras, 1495-433, Portugal
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Does it matter where you inject? scientists test Weight-Loss drug in arm, thigh, and belly
- New drug RO7830698 put to the test for COPD
- Three pill versions of one drug go head to head in the bloodstream
- Pfizer tests RSV vaccine aimed at older adults
- Radioactive tracer maps where a new drug goes in the body
- Radioactive tag lets scientists follow an experimental drug through the human body